Oleosea’s chain of custody audit has confirmed that its Omega-3 supplements branded VitalSea have obtained from Friend of the Sea the sustainability certification of Neptune Technologies & Bioressources. Oleosea has thus obtained authorization to use the Friend of the Sea logo on its packaging and marketing material.
Following an audit, Oleosea confirms that Vitalsea, its omega-3 krill oil supplement, has obtained the Friend of the Sea (FOS) certification for the sustainable harvest of krill manufactured by Neptune Technologies & Bioressources Inc. Consequently, this allows Oleosea to use the Friend of the Sea logo on its packaging and marketing material.
Neptune obtained the FOS certification by complying with strict krill sustainability criteria, which ensure that the stock is not overfished, the fishery is in compliance with the management measures, there’s no bycatch of endangered species and there is no adverse impact on the ecosystem or seabed.
“We know our customers have a strong awareness for environmental and conservation issues and Friend of the Sea recognition is an additional confirmation of Oleosea’s engagement toward sustainable use of our planet’s resources’ concludes Marganne Richard, CEO of Oleosea.
“Friend of the Sea has become the standard for sustainability in the Omega-3 supplements industry.” comments Friend of the Sea founder, Paolo Bray.
For more information please contact:
Tél. +41 26 321 26 86
Friend of the Sea
Friend of the Sea is an international non-profit certification scheme for products from sustainable fisheries and aquaculture. Certified products are fished from not overexploited nor IUCN Redlisted stocks and with selective methods which do not impact the seabed. Those originate from aquaculture are reared with respect of critical habitat, with no use of antifoulants, GMOS and growth hormones.
Oleosea is a Swiss company working in collaboration with Canadian Neptune Technologies & Bioressources. The companies are major players in the field of innovative and effective dietary supplements based on clinical studies.